Iana Malasevskaia

Dr. Iana Malasevskaia

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2024 in Expert Opinion on Therapeutic Targets
Verified
Journal Article
Closed access
MCMichal Ciebiera
Michal Ciebiera
JKJakub Kociuba
Jakub Kociuba
Mohamed AliMohamed Ali
Mohamed Ali
OLObianuju Madueke Laveaux
Obianuju Madueke Laveaux
Qiwei YangQiwei Yang
Qiwei Yang
AAAyman Al-Hendy
Ayman Al-Hendy
Uterine fibroids, the most common nonmalignant tumors affecting the female genital tract, are a significant medical challenge. This article focuses on the most recent studies that attempted to identify novel non-hormonal therapeutic targets and strategies in UF therapy. This review covers the analysis of the pharmacological and biological mechanisms of the action of natural substances and the role of the microbiome in reference to UFs. This study aimed to determine the potential role of these compounds in UF prevention and therapy. While there are numerous approaches for treating UFs, available drug therapies for disease control have not been optimized yet. This review highlights the biological potential of vitamin D, EGCG and other natural compounds, as well as the microbiome, as promising alternatives in UF management and prevention. Although these substances have been quite well analyzed in this area, we still recommend conducting further studies, particularly randomized ones, in the field of therapy with these compounds or probiotics. Alternatively, as the quality of data continues to improve, we propose the consideration of their integration into clinical practice, in alignment with the patient's preferences and consent.

1 January 2021 in Cureus
Verified
Journal Article
Open access
PDF file
IMIana Malasevskaia
Iana Malasevskaia
SSSalma Sultana
Salma Sultana
AHAiman Hassan
Aiman Hassan
AHAzza A Hafez
Azza A Hafez
FOFethi Onal
Fethi Onal
SHStacey E Heindl
Stacey E Heindl
The prevalence of obesity among women of reproductive age is growing significantly over the last years. Being obese or having a high body mass index (BMI) contributes to many diseases and pregnancy complications. This is concerning as an obese woman is at increased risk for developing several complications during pregnancy and is at increased risk for pregnancy loss, stillbirth, and metabolic disorders of a live-born child in his future. The pregnant woman's body mass index has to be monitored well during the whole pregnancy, and their diet should also be monitored to avoid future complications. Better results can be achieved if every woman would watch their weight before being pregnant for better outcomes in their future pregnancies. This review article aimed to determine the relationship between being obese or having a high BMI and pregnancy loss. Additionally, we tried to find the mechanism that is involved in pregnancy loss in obese women.

20 June 2025 in VeriXiv
Verified
Preprint
Open access
YAYusuf Adelabu
Yusuf Adelabu
IMIana Malasevskaia
Iana Malasevskaia
MBMobolanle Balogun
Mobolanle Balogun
WAWunmi Adaramoye
Wunmi Adaramoye
LBLenka Benova
Lenka Benova
ABAduragbemi Banke-Thomas
Aduragbemi Banke-Thomas

1 January 2026 in Anemia
Verified
Journal Article
Open access
YAYusuf Adelabu
Yusuf Adelabu
IMIana Malasevskaia
Iana Malasevskaia
MBMobolanle Balogun
Mobolanle Balogun
VAVictoria Adaramoye
Victoria Adaramoye
LBLenka Benova
Lenka Benova
ABAduragbemi Banke-Thomas
Aduragbemi Banke-Thomas
Background: Screening for anaemia in pregnancy and the postpartum period is an important component of maternal care to prevent associated morbidity and mortality. However, the implementation of routine screening practices for pregnancy‐related anaemia remains variable, inconsistent, and suboptimal. This review aimed to synthesise the literature on practices, facilitators, barriers, implementation strategies, and outcomes of routine screening for pregnancy‐related anaemia. Methods: This scoping review followed the JBI methodology and PRISMA‐ScR checklist with a comprehensive systematic search of seven academic databases (PubMed, EMBASE, Scopus, CINAHL, Web of Science, Global Index Medicus, and African Journals Online) and selected grey literature sources. Retrieved citations were screened, and relevant references were assessed for eligibility. Articles included were analysed qualitatively and presented descriptively by concept, comparing settings with high and low prevalence of anaemia in pregnancy. Results: We identified 9497 references and included 116 articles in this review. Clinical practice guidelines recommend universal screening for anaemia during pregnancy and selective screening in the postpartum period using automated or point‐of‐care haemoglobin testing and iron studies, with variations in screening frequency and timing. Screening coverage for anaemia in pregnancy was lower in high‐prevalence compared to low‐prevalence settings. Effective supportive supervision was the main facilitator of anaemia screening in pregnancy, while lack of screening materials served as the main barrier, particularly in high‐prevalence settings. Training health workers on point‐of‐care testing in high‐prevalence settings was the most common strategy used to improve the implementation of routine screening for anaemia in pregnancy, and its feasibility was the most studied implementation outcome. Conclusion: Implementing routine screening practices for pregnancy‐related anaemia in all settings will benefit from harmonised clinical practice guidelines. Efforts are required to address implementation challenges and move from the early phase of implementation towards sustainability. Future research should aim to fill the knowledge gaps in implementing anaemia screening, particularly in the postpartum period.

2 November 2026 in Egyptian Pediatric Association Gazette
Verified
Journal Article
Open access
PDF file
DADamilare Michael Akintunde
Damilare Michael Akintunde
SNSAI JAHNU SREE REDDY NARLA
SAI JAHNU SREE REDDY NARLA
DBDiana Baltodano
Diana Baltodano
SMSai Charan Mekala
Sai Charan Mekala
SSSahana Srinivasan
Sahana Srinivasan
IMIana Malasevskaia
Iana Malasevskaia
Background: The World Health Organization defines antimicrobial self‑medication as the use of antimicrobials without medical supervision. High antimicrobial self‑medication prevalence among children and adolescents in Sub‑Saharan Africa raises critical public health concerns. This systematic review synthesizes evidence on prevalence, determinants, and sources of antimicrobial self‑medication exclusively among children and adolescents under 18 years in Sub‑Saharan Africa. Main body: Following PRISMA 2020 guidelines, we searched PubMed/MEDLINE, ScienceDirect, Europe PMC, and EBSCO Open Dissertations from January 2015 to June 30, 2025. Initial screening and data extraction were completed by December 2025. During the revision process, we performed an updated search on June 24, 2026, to capture recently published studies. Two reviewers independently screened records, assessed quality, and performed narrative synthesis. Thirteen studies met inclusion criteria. Antimicrobial self‑medication prevalence ranged from 21.9% to 92%, highest in Nigeria. Frequently self‑administered antibiotics included amoxicillin (11.4%–80.6%), ampicillin‑cloxacillin (10.3%–50.9%), penicillin (25%), and tetracycline (~ 20%); antimalarials included chloroquine (78%) and quinine (15%). Main sources were drugstores/pharmacies (up to 99.7%), pharmacy staff (70%), and leftover medications (21%). Key determinants were lower parental education, distance to healthcare over 5 km, and febrile symptoms (fever up to 85.1%, cough up to 80.5%). Conclusion: Antimicrobial self‑medication increases antimicrobial exposure and represents a recognized contributor to antimicrobial resistance, though no included study directly measured resistance outcomes. Targeted public health interventions including caregiver health education and stricter enforcement of prescription‑only regulations are imperative. This review provides the first exclusive synthesis of antimicrobial self‑medication among Sub‑Saharan African children and adolescents, informing context‑specific interventions.

8 August 2026 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
IMIana Malasevskaia
Iana Malasevskaia
DRDelvy Rebellow
Delvy Rebellow
RCRoopa Chalasani
Roopa Chalasani
AKAlousious Kasagga
Alousious Kasagga
DADamilare Michael Akintunde
Damilare Michael Akintunde
ICIsha Chopra
Isha Chopra